COMMITMENTS AND CONTINGENCIES - Fair Value Contingent Consideration, Balance Information (Details) - Contingent Consideration Liability - Fair Value, Inputs, Level 3 - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Arkis
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, End of Period	$ 14,000	$ 15,400
Arkis | Other Current Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	3,691	3,415
Transfers	59
Change in fair value of contingent consideration liabilities	0	17
Balance, End of Period	3,750	3,432
Arkis | Other Long-term Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	11,408	11,746
Transfers	(59)
Change in fair value of contingent consideration liabilities	(1,065)	265
Balance, End of Period	10,284	12,011
Derma Sciences | Other Long-term Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	230	230
Transfers	0
Change in fair value of contingent consideration liabilities	0	0
Balance, End of Period	230	230
ACell | Other Current Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	0
Transfers	4,885
Change in fair value of contingent consideration liabilities	0
Balance, End of Period	4,885
ACell | Other Long-term Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, Beginning of Period	21,800	0
Transfers	(4,885)
Additions from acquisition of ACell		23,900
Change in fair value of contingent consideration liabilities	300	0
Balance, End of Period	$ 17,215	$ 23,900